GUANGZHOU, China, Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ('Baird Medical' or the 'Company'), a leading microwave ablation ('MWA') medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced that the Company will participate in the following investor conference. Baird Medical's management plans to host one-on-one and small group meetings with institutional investors at the conference.
Roth's 3rd Annual Healthcare Opportunities Conference